Post-Market Study of Robotic-Arm Assisted Total Knee Arthroplasty
1 other identifier
interventional
400
1 country
4
Brief Summary
This is an early user evaluation of the robotic-assisted total knee arthroplasty platform. The objective of this surgeon group is to capture data on the defined objectives and provide Stryker with feedback.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2016
Typical duration for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2016
CompletedFirst Submitted
Initial submission to the registry
February 7, 2017
CompletedFirst Posted
Study publicly available on registry
April 10, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2019
CompletedApril 10, 2017
February 1, 2017
3 years
February 7, 2017
April 4, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Component alignment
CT scan measurement
6 weeks post knee arthroplasty
Study Arms (2)
Manual instrument total knee replacement
ACTIVE COMPARATORRobitic arm total knee replacement
ACTIVE COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- Patient requires primary total knee surgery
- Patient is willing and able to comply with postoperative follow-up requirements and self evaluations
- Patient is willing to sign an IRB approved informed consent
- Patient is at least 18 years of age
You may not qualify if:
- Patient has a BMI \> 50
- Patient is skeletally immature
- Patient has an active infection or suspected infection in or about the joint
- Bone stock that is inadequate to support fixation of the prosthesis
- Neuromuscular disorders, muscular atrophy or vascular deficiency in the affected limb rendering the procedure unjustified.
- Patients with mental or neurological conditions which may be incapable of following instructions.
- Blood supply limitations
- Collateral ligament insufficiency.
- Patients with prior HTOs or Unis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Rothman Institute Orthopaedicslead
- Stryker Orthopaedicscollaborator
Study Sites (4)
Athens Orthopedic Clinic
Athens, Georgia, 30606, United States
Rothman Institute
Egg Harbor, New Jersey, 08234, United States
Cleveland Clinic
Cleveland, Ohio, 44195, United States
Rothman Institute
Philadelphia, Pennsylvania, 19107, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 7, 2017
First Posted
April 10, 2017
Study Start
June 1, 2016
Primary Completion
June 1, 2019
Study Completion
June 1, 2019
Last Updated
April 10, 2017
Record last verified: 2017-02